Suna Yapalı

Assoc. Prof. Suna Yapalı is an experienced gastroenterologist and hepatologist with a strong focus on advanced endoscopy and gastrointestinal motility. She completed specialized training in Advanced Endoscopy and Motility at the Academic Medical Center in Amsterdam in 2017. Since 2008 she has been affiliated with Acıbadem Health Group, where she provides patient-centered care, performs complex endoscopic procedures, and manages a wide range of liver and digestive disorders. She is an active member of leading professional societies, including the American Gastroenterological Association, the American Association for the Study of Liver Diseases, the European Association for the Study of the Liver, the Turkish Association for Liver Research, the Turkish Gastroenterology Association, and the National Inflammatory Bowel Diseases Association. Her memberships reflect a commitment to staying current with advances in liver disease, inflammatory bowel disease, and endoscopic techniques. Known for combining clinical expertise with a compassionate approach, she treats patients with hepatitis, cirrhosis, inflammatory bowel disease, and functional GI disorders, and performs advanced diagnostic and therapeutic endoscopic interventions. She remains engaged in professional development and collaboration to improve patient outcomes and advance care in hepatology and gastroenterology.

Education

• 2017 Advanced Endoscopy and Motility, Academic Medical Center, Amsterdam Netherlands
• 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, USA / Hepatology Research Fellowship
• 2012 Ege University Faculty of Medicine Gastroenterology
• 2008 Marmara University Faculty of Medicine Internal Medicine
• 2001 Istanbul University Cerrahpasa Faculty of Medicine

Experience

• 2012 – 2014 University of Michigan, Division of Gastroenterology and Hepatology, Ann Arbor, MI, USA
• 2009 – 2012 Ege University Faculty of Medicine, Department of Gastroenterology
• 2008 – 2009 Department of Gastroenterology, Haydarpaşa Numune Training and Research Hospital
• 2008 Acibadem Health Group
• 2002 – 2008 Marmara University Faculty of Medicine Department of Internal Medicine

Memberships

• American Gastroenterology Association
• American Association for the Study of Liver Disease
• European Association for the Study of Liver Disease
• Turkish Association for Liver Research
• Turkish Gastroenterology Association
• National Inflammatory Bowel Diseases Association

Publications

• Management of Hepatitis B: My Practice and How it Relates to the Guidelines.
  Clin Gastroenterol Hepatol 2014;12(1):16-26. Yapali S, Talaat N, Lok AS.
• Outcome of chronic hepatitis B patients who do not meet criteria for antiviral treatment at presentation.
  Clin Gastroenterol Hepatol 2014 Jul 17. pii: S1542- 3565(14)01048-9. doi: 10.1016/j.cgh.2014.07.019. Yapali S, Talaat N, Fontana RJ, Oberhelman K, Lok AS.
• The potential benefit of telbivudine does not outweigh its high rate of antiviral drug resistance and other adverse effects.
  Gastroenterology 2014;146(1)15-9. Yapali S, Lok AS.
• Does suppression of HBV replication by antiviral therapy confer the same benefit as host immune control of HBV?
  Gut 2014, Apr 1. doi: 10.1136/gutjnl-2014-306935. Yapali S, Lok AS.
• Should this patient be treated? Best practices in identifying cirrhosis and HCC in patients infected with HBV ? Role of prediction models.
  Johns Hopkins Medicine eViralHepatitis Review 2012, Volume 3, Issue 3. Yapali S, Lok AS.
• Giant esophageal lipoma presenting with gastroesophageal reflux symptoms.
  J Gastrointestinal Liver Diseases 2013;22(1):8. Yapali S, Oruc N, Harman M, Aydin A.
• A severe case of esophageal ulcer causing a tight stricture despite long-term D-penicillamine treatment.
  Wiener Klin Wochenschr 2014 Yapali S, Turan I, Ozutemiz O, Tekesin O.
• Sexual activity does not predispose to reflux episodes in patients with gastroesophageal reflux disease.
  UEG Journal 2014 DOI: 10.1177/2050640614550851 Bor S, Valytova E, Yapali S, Yildirim E, Vardar R.
• Predictors of histologic progression and clinical outcomes for patients with chronic hepatitis C: A systematic review
  Aliment Pharmacol Ther 2014;40(8):863-79. doi: 10.1111/apt.12921. Konerman M, Yapali S, Lok AS.
• Changes in the characteristics of Hepatitis C patients seen in a liver center in the United States during the last decade.
  J of Viral Hepat 2014 2014 Oct 14. doi: 10.1111/jvh.12343. Talat N, Yapali S, Fontana RJ, Conjeevaram H, Lok AS.